NEW YORK PRESBYTERIAN HOSPITAL
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $21M
- Transactions
- 1,226
- Companies
- 40
- Average per transaction
- $17,145
Who reported the payments
| Ipsen Biopharmaceuticals, Inc | $3,781,440 |
| Pfizer | $2,390,195 |
| Merck | $2,134,196 |
| Agios Pharmaceuticals, Inc. | $1,566,475 |
| Jazz Pharmaceuticals Inc. | $1,321,442 |
| Jenavalve Technology, Inc. | $1,170,129 |
| Gilead | $1,019,369 |
| Cardiovascular Systems Inc. | $962,494 |
| AbbVie | $858,000 |
| Novartis | $712,782 |
| Cathworks, Inc. | $556,061 |
| Angiodynamics, Inc. | $352,583 |
| Siemens Medical Solutions USA, Inc. | $344,000 |
| Plexxikon Inc. | $315,873 |
| Biofire Diagnostics, LLC | $251,145 |
| Epizyme, Inc. | $226,200 |
| Acutus Medical, Inc. | $211,500 |
| C. R. Bard, Inc. & Subsidiaries | $209,228 |
| Hill-rom Holdings, Inc | $155,280 |
| Procept Biorobotics Corporation | $137,487 |
| Vascular Graft Solutions Inc | $134,558 |
| Stryker | $133,767 |
| Vascular Solutions, Inc. | $99,319 |
| National Marrow Donor Program | $98,875 |
| Clearpoint Neuro, Inc. | $83,503 |
| Medtronic | $76,784 |
| Abbott | $75,615 |
| Evoendo, Inc | $74,286 |
| Foundation Medicine, Inc. | $72,500 |
| Progenics Pharmaceuticals, Inc. | $71,962 |
| Organ Recovery Systems, Inc. | $68,942 |
| Align Technology, Inc. | $63,672 |
| Arrow International, Inc. | $62,452 |
| Berlin Heart Inc | $60,880 |
| Medicem Inc. | $58,055 |
| Ferring Pharmaceuticals Inc. | $57,837 |
| Sage Therapeutics, LLC | $57,754 |
| AMAG Pharmaceuticals, Inc. | $55,800 |
| Johnson & Johnson | $55,460 |
| Biocircuit Technologies Inc | $50,000 |